Montecito Bank & Trust lessened its holdings in shares of Clorox Co (NYSE:CLX) by 9.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 4,712 shares of the company’s stock after selling 500 shares during the quarter. Montecito Bank & Trust’s holdings in Clorox were worth $721,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Mn Services Vermogensbeheer B.V. boosted its position in Clorox by 0.6% during the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 70,968 shares of the company’s stock worth $11,388,000 after acquiring an additional 400 shares during the period. Deutsche Bank AG lifted its holdings in shares of Clorox by 10.2% in the fourth quarter. Deutsche Bank AG now owns 307,703 shares of the company’s stock valued at $47,425,000 after buying an additional 28,361 shares during the period. Phocas Financial Corp. acquired a new stake in shares of Clorox in the fourth quarter valued at $193,000. SlateStone Wealth LLC lifted its holdings in shares of Clorox by 13.6% in the first quarter. SlateStone Wealth LLC now owns 5,043 shares of the company’s stock valued at $809,000 after buying an additional 605 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Clorox by 1.1% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 35,017 shares of the company’s stock valued at $5,619,000 after buying an additional 384 shares during the period. Institutional investors own 77.45% of the company’s stock.

CLX has been the subject of several research analyst reports. Deutsche Bank lowered Cogent Communications from a “buy” rating to a “hold” rating in a report on Thursday, May 2nd. Zacks Investment Research upgraded DLH from a “sell” rating to a “hold” rating in a report on Tuesday, July 9th. Argus lowered Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. JPMorgan Chase & Co. set a $60.00 price objective on Bayerische Motoren Werke and gave the company a “sell” rating in a report on Monday, April 8th. Finally, Wells Fargo & Co set a $29.00 price objective on Establishment Labs and gave the company a “buy” rating in a report on Friday, July 12th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $154.67.

In related news, SVP Denise Garner sold 20,399 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the transaction, the senior vice president now directly owns 4,896 shares of the company’s stock, valued at $771,658.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.40% of the stock is owned by insiders.

Shares of Clorox stock traded up $2.81 on Tuesday, reaching $164.40. 1,212,016 shares of the company were exchanged, compared to its average volume of 1,001,114. The business has a fifty day simple moving average of $156.32. The stock has a market cap of $20.62 billion, a price-to-earnings ratio of 26.26, a price-to-earnings-growth ratio of 4.74 and a beta of 0.38. The company has a debt-to-equity ratio of 2.93, a current ratio of 1.10 and a quick ratio of 0.66. Clorox Co has a fifty-two week low of $128.27 and a fifty-two week high of $167.70.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.03). The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.57 billion. Clorox had a return on equity of 108.82% and a net margin of 12.68%. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same period last year, the firm earned $1.37 earnings per share. As a group, research analysts anticipate that Clorox Co will post 6.29 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be given a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, July 30th. This is a positive change from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.58%. Clorox’s payout ratio is 61.34%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Outperform Rating

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.